Navigating you through drug development
We are Ardena, a fully integrated Contract Development & Manufacturing Organization (CDMO) with a core focus on bringing molecules to the clinics.
We distinguish ourselves from other contractors by:
- being an end-to-end clinical supply chain integrator
- focusing on early phase development of experimental drugs
- providing a dossier centric development approach
- offering nanotechnology services enhancing bio-availability and/or pursuing targeted delivery
- offering bioanalytical services in preclinical and clinical stages
We operate from six state-of-the-art, purpose-built facilities across Western and Northern Europe.
We service a broad and global customer base including prominent blue-chip companies. We have an outstanding quality and regulatory track-record, verified by full GMP and GLP compliance.
About Ardena
A dedicated partner with an integrated approach from drug discovery to clinic
We’re a pharmaceutical CDMO that guides companies through the drug discovery and development process to help create effective and compliant drug products for clinical trials. Headquartered in Ghent (Belgium), we also have facilities in the Netherlands, Sweden and Latvia. We serve a global customer base, ranging from emerging biotech to tier-one pharmaceutical companies.
Why Ardena?
Drug and dossier development working hand in hand to deliver unrivalled quality
Our dossier centric approach to drug development fast tracks your product to compliance. By compiling your regulatory dossier in parallel with drug development, we can identify and overcome hurdles, and ultimately save you time.
We also have a number of areas of specialist expertise, including solid state research, bio-availability enhancement and modified release, meaning we can handle even the toughest development challenges.
